SOURCE: Bollinger Report

January 19, 2012 09:00 ET

A Forward Look, The Year Ahead - Featured Research on The Cooper Companies, Inc. and Covidien plc

HONG KONG--(Marketwire - Jan 19, 2012) - Today, www.BollingerReport.com introduced featured coverage of The Cooper Companies, Inc. (NYSE: COO) and Covidien plc (NYSE: COV). Full research reports are available to readers at: www.BollingerReport.com/index.php?sm1=COO&sm2=COV.

Economic fundamentals leading into 2012 have set a generally positive pace with GDP growth likely to pick up through the coming year. However, there are several important caveats to note as the world economy continues to face headwinds and risks weigh to the downside. Positive outlooks are conditional on fiscal policy in payroll taxes and unemployment insurance benefits and upon the easing of the European debt situation. A repeat of volatility experience in 2011 is likely in 2012, as perceptions about the strength of the U.S. economy and the euro zone will vary over time as events unfold.

Despite the current situation, our team continues to identify high momentum situations with growth potential -- there remains strong opportunity within careful discretion.

Bollinger Report screened and selected The Cooper Companies, Inc. for its current position within the healthcare industry. The Cooper Companies, Inc. (Cooper) is a global medical products company that serves the specialty healthcare market through its two business units, CooperVision, Inc. (CVI) and CooperSurgical, Inc. (CSI). CVI develops, manufactures and markets a range of contact lenses for the global vision correction market. A copy of this report featuring The Cooper Companies, Inc. (NYSE: COO) is available at: www.BollingerReport.com/index.php?sm1=COO.

Bollinger Report is featuring Covidien plc for its changing role within the healthcare industry. Covidien Public Limited Company, formerly Covidien Ltd. is engaged in the development, manufacture and sale of healthcare products for use in clinical and home settings. The Company operates its businesses through three segments: Medical Devices, Pharmaceuticals and Medical Supplies. To download researches and analysis on Covidien plc (NYSE: COV) we welcome investors to visit: www.BollingerReport.com/index.php?sm2=COV.

About Bollinger Report
Bollinger Report has come to be known among its peers as a trusted source of information for both investors and technical traders. Our online content is continually updated, bringing fresh new researches and analyses to the investment community.

Contact:

Contact Information